CME: Perspectives on Psoriatic Disease & Atopic Dermatitis: The Evolving Treatment Landscapes

Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
Forefront Perspectives Dermatology

Perspectives on Psoriatic Disease & Atopic Dermatitis: The Evolving Treatment Landscapes

Program Information
Perspectives on Psoriatic Disease & Atopic Dermatitis: The Evolving Treatment Landscapes
Are you using these treatment options to help your patients living with two of the most common inflammatory skin diseases?

Available credits: 0.50

Time to complete: 30 Minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    When it comes to managing diseases like psoriasis, psoriatic arthritis, and atopic dermatitis, there’s a lot of factors that affect your approach. To explore how we can use the available treatments to our advantage, Dr. John Russell sits down with Dr. April Armstrong and Heather, a patient who shares her experience of living with both psoriasis and psoriatic arthritis. You could also access resources, including mechanisms of action videos, which were created under the guidance of Dr. Armstrong.

  • Learning Objectives

    As a result of participation in this educational activity, participants should increase their ability to

    1. Describe the evolving treatment landscapes and updates in clinical practice guidelines for psoriasis and psoriatic arthritis
    2. Identify therapeutic strategies for atopic dermatitis
    3. Discuss psoriatic disease burden and shared decision making in clinical practice
  • Target Audience

    The target audience for this educational activity is dermatologists, nurse practitioners, and physician assistants who specialize in dermatology. Other clinicians who provide care for patients with psoriasis, psoriatic arthritis, and atopic dermatitis may benefit from participation in this activity.

  • Disclosure of Conflicts of Interest

    Educational activities provided by Forefront Collaborative must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s)*. For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias. Disclosures appear below.

    *The ACCME defines a commercial interest as any entity producing, marketing, reselling, or distributing health care goods or services consumed by or used on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.

    The following individuals have indicated that neither they nor their spouses/partners have had, in the past 12 months, financial relationship(s) with commercial interests relative to the content of this CME activity:

    • Planners (Forefront Collaborative)
      • Marianna Shershneva, MD, PhD
      • Jessica Porucznik
    • Patient
      • Heather

    The following individuals have disclosed that they and/or their spouse/partner has had a financial relationship in the past 12 months:

    • Faculty: April W. Armstrong, MD, MPH
      • Consultant: AbbVie, Bristol-Myers Squibb, Dermavant, Janssen, LEO Pharma, Lilly, Modernizing Medicine, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi Genzyme, Science 37
      • Researcher: AbbVie, Bristol-Myers Squibb, Dermira, Janssen, Kyowa Hakko Kirin, LEO Pharma, Lilly, Novartis, Regeneron, Sanofi Genzyme, UCB
    • Planner (Faculty): Lakshi Aldredge, MSN, ANP-BC, DCNP
      • Consultant and speaker: AbbVie, Celgene, Lilly, Novartis, Sanofi, Sun Pharma, Regeneron
  • Accreditation and Credit Designation Statements

    Accreditation Statement

    Forefront Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Credit Designation Statements

    Forefront Collaborative designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Interstate Postgraduate Medical Association is approved by the California Board of Registered Nursing, Provider Number 6971, for 0.5 contact hours. Each person should retain this certificate for 4 years after the course has been completed. RNs outside of California must verify with their licensing agency for approval of this course.

    This activity is approved for .5 contact hour(s) of continuing education (which includes up to .50 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 19073794.  This activity was planned in accordance with AANP CE Standards and Policies.

  • Provider(s)/Educational Partner(s)

    This activity is provided by Forefront Collaborative in collaboration with Interstate Postgraduate Medical Association.


  • Commercial Support

    This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding, visit

  • Disclaimer

    The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views or recommendations of Forefront Collaborative, Interstate Postgraduate Medical Association, and Lilly.

    The content of this activity was independently peer reviewed by two reviewers. The reviewers of this activity have no relevant financial relationships to disclose.

    This continuing medical education activity will include reference(s) to unlabeled or unapproved uses of drugs.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio


Programs 11/19/19

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.